EW Stock: Price, Earnings History and SEC Filings
Edwards Lifesciences Corporation (EW) last traded at $92.01, down 2.57% on the latest session and up 6.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.78 against an analyst estimate of $0.73, a beat of 6.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
EW earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 23, 2026 | $0.78 | $0.73 | +6.85% |
| Mar 2026 | Apr 23, 2026 | $0.78 | $0.75 | +4.00% |
| Dec 2025 | Feb 10, 2026 | $0.58 | $0.62 | -6.45% |
| Sep 2025 | Oct 30, 2025 | $0.67 | $0.59 | +13.56% |
EW beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How EW reacts to earnings
Across its last 8 earnings releases, EW moved 4.0% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-07-23 | After close | -1.42% |
| 2026-04-23 | After close | +5.56% |
| 2026-02-10 | After close | +2.96% |
| 2025-10-30 | After close | -1.23% |
| 2025-07-24 | After close | +5.54% |
| 2025-04-23 | After close | +6.63% |
| 2025-02-11 | After close | +6.92% |
| 2024-10-24 | After close | -1.38% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
EW financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $6.1B | $1.1B | $1.3B | 17.7% | $1.83 |
| 2024 | $5.4B | $4.2B | $290M | 76.7% | $6.97 |
| 2023 | $5.0B | $1.4B | $643M | 28.0% | $2.30 |
| 2022 | $4.5B | $1.5B | $974M | 34.1% | $2.44 |
| 2021 | $5.2B | $1.5B | $1.4B | 28.7% | $2.38 |
| 2020 | $4.4B | – | $647M | – | $1.30 |
| 2019 | $4.3B | – | $929M | – | $1.64 |
| 2018 | $3.7B | – | $688M | – | $1.13 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for EW
- 8-K · Aug 28, 2026Officer or director change
- 10-Q · Aug 4, 2026
- 8-K · Jul 23, 2026Results of operations, Financial statements and exhibits
- 8-K · May 8, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 10-Q · May 6, 2026
- 8-K · May 4, 2026Officer or director change, Regulation FD disclosure
- 8-K · Apr 23, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Mar 26, 2026
- 10-K · Feb 25, 2026
- 8-K · Feb 10, 2026Results of operations, Financial statements and exhibits
Insider filing activity
EW insiders filed 10 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
EW news
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?Oct 30, 2026 · finance.yahoo.com
- Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsOct 30, 2026 · finance.yahoo.com
- What Sent GE HealthCare Stock Higher?Oct 29, 2026 · trefis.com
- SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?Oct 28, 2026 · finance.yahoo.com
- ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?Oct 28, 2026 · finance.yahoo.com
- WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?Oct 27, 2026 · finance.yahoo.com
- GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?Oct 27, 2026 · finance.yahoo.com
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Oct 23, 2026 · finance.yahoo.com
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) is a US-listed public company on NYSE. The SEC classifies its business as Orthopedic Prosthetic & Surgical Appliances & Supplies. It is incorporated in DE. Its fiscal year ends in December.